UNSPSC 51302501: Liranaftate

This classification denotes an antifungal agent with the molecular formula C18H20N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5253IGO5X3, chemically known as o-(5,6,7,8,-tetrahydro-2-naphthyl) 6-methoxy-n-methylthio-2-pyridinecarbamate but generally known as liranaftate, which bears US NIH Compound Identifier 3936. European Medicines Agency schedules Liranaftate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08528MIG. The term LIRANAFTATE is an International Non-Proprietary Name.

UNSPSC 51302501 Liranaftate is a Commodity code under which state and local governments procure medical aid and first aid supplies for emergency response and healthcare operations. The code encompasses antiseptic sprays, hydrogen peroxide, pain relievers, bandages, first aid kits, emergency blankets, and related medical consumables used by fire rescue departments, emergency services, and public health agencies. Recent solicitations show that issuing bodies include municipal fire and rescue departments, which are primary consumers of these supplies for emergency preparedness and field response. The scope includes procurement by individual line item or aggregate award, with vendors required to meet documentation, compliance, and minority business certification standards where applicable.

The code shows recent activity in Florida, where the City of Tampa Fire Rescue Department posted ITB 25-P-00157 on April 24, 2026 for a comprehensive medical aid supplies procurement covering 32 product categories with annual quantities ranging from 1 to 2,700 units per item and a total department budget of $100,000. The solicitation offered set-aside opportunities for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises, with bid discounts up to $10,000 and $20,000 respectively, capped at $10,000 aggregate. The initial award period runs one year with two optional one-year renewals, and all medications require a minimum nine-month expiration date from acceptance. Bidders were required to submit a Letter of Intent within ten work days of the original bid opening and provide subcontract agreements before commencing work with minority or women-owned subcontractors.